search results for

refine results

sort by

Date
Relevance

result type

Articles
Video

Wires
Press Releases

FDA: Eli Lilly drug reduces cardiovascular death

Shares of Eli Lilly gains momentum on news of an FDA drug approval. CNBC's Seema Mody reports.

Source: CNBC.com

Bringing foreign drugs into the US market is a dangerous concept: Merck CEO

CNBC’s Meg Tirrell talks to Kenneth Frazier, Merck CEO, at the fifth annual Forbes Healthcare Summit in New York about the future of drug pricing under the Trump administration as well as Alzheimer’s research.

Source: CNBC.com

Drug bust hits healthcare stocks

The "Fast Money" traders weigh in on Eli Lilly and Juno Therapeutics, following failed drug trials.

Source: CNBC.com

Still upside in Eli Lilly despite drug failure: Divan

Vamil Divan, Credit Suisse senior analyst, discusses Eli Lilly's failed Alzheimer's drug trial and the effect on its stock price.

Source: CNBC.com

Analyst on LLY: In general, I believe Biogen drug is better

Ronny Gal, Bernstein senior analyst, weighs in on Eli Lilly's failed Alzheimer's drug study results.

Source: CNBC.com

Eli Lilly & Juno Therapeutics plummet after failed drug trials

The “Fast Money Halftime Report” traders weigh in on the biotech sector, with Eli Lilly and Juno Therapeutics stocks dropping significantly.

Source: CNBC.com

Stocks to Watch: November 23, 2016

Eli Lilly, Urban Outfitters and Alphabet stocks are making headlines this Wednesday morning.

Source: CNBC.com

Lilly Alzheimer's drug does not slow memory loss: Study

Lilly shares tumble after its Alzheimer drug study did not meet its goals, reports CNBC's Meg Tirrell. Obviously we are disappointed but we remain committed to Alzheimer's disease, says John Lechleiter, Eli Lilly CEO. And David Ricks, Eli Lilly incoming CEO, weighs in on the company's future growth prospects.

Source: CNBC.com

Eli Lilly may react strongly to Alzheimer's drug trial

CNBC's Meg Tirrell reports on Eli Lilly's Alzheimer's drug trial plans and speaks to incoming CEO David Ricks.

Source: CNBC.com

Eli Lilly's new approach for Alzheimer's

CNBC's Meg Tirrell reports on Eli Lilly's drug being tested to treat Alzheimer's disease.

Source: CNBC.com